(NASDAQ: PYPD) Polypid's forecast annual earnings growth rate of -64.35% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.33%.
Polypid's earnings in 2026 is -$34,169,000.On average, 6 Wall Street analysts forecast PYPD's earnings for 2026 to be -$28,458,316, with the lowest PYPD earnings forecast at -$30,149,468, and the highest PYPD earnings forecast at -$23,892,753. On average, 4 Wall Street analysts forecast PYPD's earnings for 2027 to be -$17,175,476, with the lowest PYPD earnings forecast at -$20,872,709, and the highest PYPD earnings forecast at -$12,997,657.
In 2028, PYPD is forecast to generate $3,899,297 in earnings, with the lowest earnings forecast at $3,746,384 and the highest earnings forecast at $4,013,982.